₹945
▼ -21.16 -2.19%
17 Jul 2026
NSE Listed
Natco Pharma Ltd. (NATCOPHARM)
Volume: 3,34,009Avg Vol 1W: 4,35,728.8Avg Vol 1M: 6,42,85852W Range:₹789₹1,226.8
Key Ratios
Checked 11h agoMarket Cap₹17,306 Cr
Current Price₹945
Previous Close₹966.16
High / Low (52w)₹1,226.8 / ₹789
Volume3,34,009
Avg Vol (1W)4,35,728.8
Avg Vol (1M)6,42,858
Stock P/E64.59
Book Value₹514.83
Dividend Yield52%
ROE15.38%
ROA12.39%
Revenue (TTM)₹4,784 Cr
Revenue Growth10.8%
Profit Margin34.78%
Total Debt₹0 Cr
Shares Outstanding18 Cr
Face Value₹2
EPS (TTM)₹79.2
P/B1.88
Debt / Equity0.05
50 DMA₹969.89
200 DMA₹934.38
Day change-2.19%
Price Chart
₹945▼ 8.50% · 1Y
2025-07-172026-07-16
20-day avg volume: 6.4L shares
Pros
- Healthy return on equity of 15.4%.
- Pays a dividend yield of 52.0%.
- Company is almost debt-free.
Cons
- Stock trades at a high P/E of 65.
Quarterly Results
| Metric | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹1,363 Cr | ₹1,371 Cr | ₹475 Cr | ₹1,221 Cr | ₹1,329 Cr | ₹1,363 Cr | ₹647 Cr | ₹739 Cr |
| EBITDA | ₹809 Cr | ₹822 Cr | ₹168 Cr | ₹516 Cr | ₹575 Cr | ₹627 Cr | ₹171 Cr | ₹155 Cr |
| Net Profit | ₹669 Cr | ₹677 Cr | ₹133 Cr | ₹407 Cr | ₹481 Cr | ₹518 Cr | ₹152 Cr | ₹268 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹2,225 Cr | ₹2,225 Cr | ₹2,022 Cr | ₹2,156 Cr | ₹2,044 Cr | ₹2,812 Cr | ₹4,127 Cr | ₹4,784 Cr |
| EBITDA | ₹903 Cr | ₹844 Cr | ₹590 Cr | ₹593 Cr | ₹220 Cr | ₹876 Cr | ₹1,693 Cr | ₹2,315 Cr |
| Net Profit | ₹696 Cr | ₹644 Cr | ₹461 Cr | ₹441 Cr | ₹170 Cr | ₹715 Cr | ₹1,388 Cr | ₹1,885 Cr |
| EPS | 39.13 | 34.87 | 25.26 | 24.2 | 9.32 | 39.18 | 77.34 | 105.26 |
Balance Sheet
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹3,715 Cr | ₹4,303 Cr | ₹4,588 Cr | ₹4,792 Cr | ₹5,109 Cr | ₹5,657 Cr | ₹6,906 Cr | ₹8,631 Cr |
| Total Liabilities | ₹639 Cr | ₹812 Cr | ₹803 Cr | ₹669 Cr | ₹846 Cr | ₹784 Cr | ₹1,053 Cr | ₹1,019 Cr |
| Equity | ₹3,076 Cr | ₹3,491 Cr | ₹3,785 Cr | ₹4,123 Cr | ₹4,264 Cr | ₹4,874 Cr | ₹5,853 Cr | ₹7,612 Cr |
| Total Debt | — | — | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating | ₹668 Cr | ₹848 Cr | ₹525 Cr | ₹429 Cr | ₹95 Cr | ₹1,027 Cr | ₹1,498 Cr | ₹2,069 Cr |
| Investing | ₹-1,115 Cr | ₹-612 Cr | ₹-167 Cr | ₹-103 Cr | ₹-5 Cr | ₹-477 Cr | ₹-1,033 Cr | ₹-1,414 Cr |
| Financing | ₹651 Cr | ₹-51 Cr | ₹-251 Cr | ₹-186 Cr | ₹35 Cr | ₹-363 Cr | ₹-247 Cr | ₹-211 Cr |
| Free Cash Flow | ₹668 Cr | ₹848 Cr | ₹525 Cr | ₹429 Cr | ₹95 Cr | ₹1,027 Cr | ₹1,498 Cr | ₹2,069 Cr |
Shareholding
Promoter 49.42% Institutions 22.61% Public 27.97%
Efficiency & Working Capital
ROCE15.4%
Interest Coverage96.9
Dividend Payout—
Debtor Days103 d
Inventory Days63 d
Payable Days23 d
Cash Conversion Cycle143 d
Working Capital Days166 d
Shareholding Details
As of 2026-06-30
Promoter49.4%
FII17%
DII5.6%
Institutions22.6%
Public28%
Promoter Pledge0%
No. of Shareholders4,03,166
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 49.7% | 49.7% | 49.7% | 49.7% | 49.6% | 49.6% | 49.6% | 49.6% | 49.5% | 49.5% | 49.4% | 49.4% |
| FIIs | 12.8% | 13.7% | 16.1% | 17.5% | 17.5% | 17.9% | 17.5% | 15.5% | 14.1% | 15.2% | 17.4% | 17% |
| DIIs | 14% | 11.2% | 9.7% | 7.9% | 6.8% | 5.6% | 5.6% | 5.8% | 5.9% | 5.4% | 5.5% | 5.6% |
| Public | 23.5% | 25.3% | 24.5% | 25% | 26.1% | 26.9% | 27.3% | 29.1% | 30.6% | 30% | 27.8% | 28% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 1,63,753 | 2,07,571 | 2,28,467 | 2,51,485 | 3,02,944 | 3,45,332 | 4,05,222 | 4,29,434 | 4,19,699 | 4,24,167 | 4,10,970 | 4,03,166 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202503 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| V C Nannapaneni | Shareholding of Promoter and Promoter Group | 15.7% | 2.80 Cr |
| Time Cap Pharma Labs Private Limited | Shareholding of Promoter and Promoter Group | 9.6% | 1.72 Cr |
| Venkata Satya Swathi Kantamani | Shareholding of Promoter and Promoter Group | 8.9% | 1.59 Cr |
| Natsoft Information Systems Pvt Ltd | Shareholding of Promoter and Promoter Group | 8.8% | 1.58 Cr |
| Belgrave Investment Fund | Public Shareholding | 2.3% | 41,45,000 |
| Vistra Itcl India Limited A/c Neelima Nannapaneni Trust | Shareholding of Promoter and Promoter Group | 2.3% | 40,82,750 |
| Life Insurance Corporation Of India | Public Shareholding | 2.2% | 40,09,317 |
| Durga Devi Nannapaneni | Shareholding of Promoter and Promoter Group | 2% | 35,39,100 |
| Akash Bhanshali | Public Shareholding | 1% | 18,00,788 |
| Rajeev Nannapaneni | Shareholding of Promoter and Promoter Group | 0.6% | 10,78,000 |
| Vistra Itcl India Limited A/c Durgadevi Family Trust | Shareholding of Promoter and Promoter Group | 0.3% | 6,00,000 |
| T Anila | Shareholding of Promoter and Promoter Group | 0.3% | 5,64,920 |
| T Ananda Babu | Shareholding of Promoter and Promoter Group | 0.2% | 4,13,205 |
| Vidyadhari Tummala | Shareholding of Promoter and Promoter Group | 0.2% | 3,67,200 |
| Satya Vani Nannapaneni | Shareholding of Promoter and Promoter Group | 0.2% | 3,34,851 |
| Neelima Sita Nannapaneni | Shareholding of Promoter and Promoter Group | 0.1% | 1,82,960 |
| Sanjay Nannapaneni | Shareholding of Promoter and Promoter Group | 0.1% | 1,56,910 |
| Ndl Infratech Private Limited | Shareholding of Promoter and Promoter Group | 0.1% | 93,750 |
| Tummala Jansi | Shareholding of Promoter and Promoter Group | 0% | 77,100 |
| Kantamani Ratna Kumar | Shareholding of Promoter and Promoter Group | 0% | 50,000 |
| Devendranth Alapati | Shareholding of Promoter and Promoter Group | 0% | 15,000 |
| Natco Aqua Limited | Shareholding of Promoter and Promoter Group | 0% | 16,000 |
| Bapanna Alapati | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Bapineedu Tummala | Shareholding of Promoter and Promoter Group | 0% | 415 |
| Venkaiah Chowdary Nannapaneni Huf | Shareholding of Promoter and Promoter Group | 0% | 0 |
Promoter Pledges
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| Venkaiah Chowdary Nannapaneni Huf | 0 | 0% | 2026-06-30 |
| Kantamani Ratna Kumar | 0 | 0% | 2026-06-30 |
| Durga Devi Nannapaneni | 0 | 0% | 2026-06-30 |
| V C Nannapaneni | 0 | 0% | 2026-06-30 |
| Rajeev Nannapaneni | 0 | 0% | 2026-06-30 |
| Neelima Sita Nannapaneni | 0 | 0% | 2026-06-30 |
| Devendranth Alapati | 0 | 0% | 2026-06-30 |
| Bapanna Alapati | 0 | 0% | 2026-06-30 |
| Bapineedu Tummala | 0 | 0% | 2026-06-30 |
| Tummala Jansi | 0 | 0% | 2026-06-30 |
| T Ananda Babu | 0 | 0% | 2026-06-30 |
| Vidyadhari Tummala | 0 | 0% | 2026-06-30 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| V C Nannapaneni | Chairman / Executive Director / M D / Promoter | 2025 |
| Rajeev Nannapaneni | Vice Chairman & Chief Executive Officer | 2025 |
| PSRK Prasad | ED / EVP | 2025 |
| D Linga Rao | ED / President | 2025 |
| A D Murthy Chavali | Independent Non Exe. Director | 2025 |
| Vijayabhaskar Dronadula | Independent Non Exe. Director | 2025 |
| B. Lakshminarayana | Independent Non Exe. Director | 2025 |
| Kantipudi Suma | Independent Non Exe. Director | 2025 |
| Nitin Jain | Independent Non Exe. Director | 2025 |
| Chekuri Venkat Ramesh | Company Sec. & Compli. Officer | 2025 |
Segments — Geography
| Region | Revenue | Share |
|---|---|---|
| India | ₹549 Cr | 13.5% |
| USA | ₹3,060 Cr | 75.1% |
| Rest of the world | ₹468 Cr | 11.5% |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2025 | ₹2 | 40 | 36 | 36 |
Corporate Actions
| Type | Date | Value | Remark |
|---|---|---|---|
| dividend | 2026-02-18 | ₹1.5 (75%) | Interim 3 |
| dividend | 2025-11-20 | ₹1.5 (75%) | Interim 2 |
| dividend | 2025-08-19 | ₹2 (100%) | Interim 1 |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2024 | 189 | 0 | 0 | 33 | 9 | 231 |
| 2024 | 89 | 0 | 0 | 2 | 0 | 92 |
| 2024 | 0 | 0 | 0 | 15 | 0 | 15 |
Insider / Designated-Person Trades
30 recent disclosure(s)
SANJAY NANNAPANENIDisposal · 70,000
SATYA VANI NANNAPANENIDisposal · 45,000
SANJAY NANNAPANENIDisposal · 1,00,000
SATYA VANI NANNAPANENIDisposal · 23,000
SATYA VANI NANNAPANENIDisposal · 17,149
PRAGNYA RAO DONTHINENIAcquisition · 100
Substantial Acquisitions (SAST)
8 disclosure(s)
Market16/09/2025 · 23,000
Off Market26/03/2025 · 2,86,910
Donation20/03/2025 · 50,000
Off Market20/03/2025 · 50,000
Market20/08/2024 · 35,000
Market19/08/2024 - 20/08/2024 · 75,000
Company Information
🌐 www.natcopharma.co.in ↗
📍 Natco House, Road No 2 Banjara Hills, Hyderabad, Telangana, 500033
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search